China’s Smithfield Investors Look to Hong Kong for IPO

Jul 18, 2013

Source Says Smithfield Plans to List Company in Hong Kong Stock Exchange after Takeover

By Amanda Brodhagen, Farms.com

China’s Smithfield Foods Inc. bidders - Shuanghui International Holdings may list the company in Hong Kong if the proposed takeover goes through. Knowledge of this planned move was first reported by Reuters who obtained the information from an anonymous source.

The greater appetite for risk in Hong Kong would allow the new company to achieve a higher market capitalization in its IPO, compared to for example the New York Stock Exchange, where Smithfield is currently listed.

Hong Kong is an established international trade centre - its free market economy provides a reliable exit route for investors overseas if and when they decide to sell their holdings. These companies include Goldman Sachs and New Horizons.

Smithfield said it was not aware and would not speculate if the combined company’s rumoured plan is to list in the Hong Kong Stock Exchange. The value of the deal was pegged at $7.1-billion, including debt.

Video: Sweetener Effects on Gut Health - Dr. Kwangwook Kim

In this episode of The Swine Nutrition Blackbelt Podcast, Dr. Kwangwook Kim, Assistant Professor at Michigan State University, discusses the use of non-nutritive sweeteners in nursery pig diets. He explains how sucralose and neotame influence feed intake, gut health, metabolism, and the frequency of diarrhea compared to antibiotics. The conversation highlights mechanisms beyond palatability, including hormone signaling and nutrient transport. Listen now on all major platforms!

“Receptors responsible for sweet taste are present not only in the mouth but also along the intestinal tract.”

Meet the guest: Dr. Kwangwook Kim / kwangwook-kim is an Assistant Professor at Michigan State University, specializing in swine nutrition and feed additives under disease challenge models. He earned his M.S. and Ph.D. in Animal Sciences from the University of California, Davis, where he focused on intestinal health and metabolic responses in pigs. His research evaluates alternatives to antibiotics, targeting gut health and performance in nursery pigs.